この記事を読む

間質性肺炎合併肺癌の手術成績

Survival after surgery for clinical stage I non-small-cell lung cancer with interstitial pneumonia. Fukui M et al.Lung C…

この記事を読む

定位放射線治療での予後予測

Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung C…

この記事を読む

RECIST評価 大きいもの2病変で十分?

Reducing number of target lesions for RECIST1.1 to predict survivals in patients with advanced non-small-cell lung cance…

この記事を読む

コロナ感染者にワクチンの意味はあるか?

Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19. Hammerman A et al.N Engl J Med. 2022 Feb 16 Epub ahe…

この記事を読む

ペメトレキセド維持療法の投与間隔を延ばしても予後に悪影響を与えない?

Survival outcomes of alternate dosing schedule of pemetrexed as maintenance therapy in NSCLC: Single institution experie…

この記事を読む

KRASと併存するSTK11とKEAP1変異の免疫療法における意味

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected …

この記事を読む

術後補助化学療法の維持療法;IMpower010

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a r…

この記事を読む

抗がん剤治療中でもCovid19ワクチンの効果は出るのか?

Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Stud…

この記事を読む

エルロチニブ+ラムシルマブ、EGFR遺伝子変異別のサブグループ解析

RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small C…

この記事を読む

EGFR-TKI耐性後の免疫治療 vs 殺細胞性抗がん剤

A Randomized Phase II Study Comparing Nivolumab with Carboplatin-Pemetrexed for EGFR-Mutated NSCLC with Resistance to EG…